CISCRP will create a kid-friendly supplement to your standard TRS that conveys the important trial information in a way familiar to a child.
Parents may struggle to explain results, or want to empower their child to learn on their own. As all trial participants deserve to know about their trial and be thanked for their participation, each pediatric trial should provide material that a child can comprehend.
Standard plain language Trial Results Summaries (TRS) are intended for an audience with a 6th grade reading level, which equates to about 12 years old. Therefore, sponsors should consider an alternate method to reaching the trial population aged 6–12.
CISCRP will create a kid-friendly supplement to your standard TRS that conveys the important trial information in a way familiar to a child. This deliverable will follow standard TRS and best language practices and in addition, each pediatric supplement will also:
CISCRP will work with your study team to plan, develop, and deliver the pediatric supplement, including setting expectations with the clinical team. We will also work with the intended audience through user reviews with parents and children who represent the ages of trial participants.
Dominantly Inherited Alzheimer’s Disease Brochure
Expanded Registry Flyer (English)
Enfermedad de Alzheimer de herencia dominante
Expanded Registry Flyer (Spanish)
Forgetting the Little Things
Concerned About Memory Loss?
Click on the resources listed below to view the full versions of LCI’s materials.